The upregulation of lncRNA GJA9‐MYCBP and PVT1, along with increased MYC mRNA levels in ALL samples compared to healthy controls, suggests their potential role as diagnostic biomarkers for ALL. The gene discussed is MYCBP; the disease is acute lymphoblastic leukemia.